| Title: | Gefitinib and High-Dose Fractionated Radiotherapy for Carcinomatous Encephalitis from Non-Small Cell Lung Carcinoma |
| Author: |
Wong, Eric T.; Wu, Julian K.; Mahadevan, Anand
Note: Order does not necessarily reflect citation order of authors. |
| Citation: | Wong, Eric T., Julian K. Wu, and Anand Mahadevan. 2007. Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma. Biologics: Targets & Therapy 1(3): 321-324. |
| Full Text & Related Files: |
2721320.pdf (562.1Kb; PDF)
|
| Abstract: | Carcinomatous encephalitis is a rapidly fatal form of metastasis caused by miliary spread of systemic cancer into the brain parenchyma. The diagnostic criteria and optimal treatment for this disease are not well defined. We report a patient with rapid neurologic deterioration from carcinomatous encephalitis from lung adenocarcinoma. She was treated with gefitinib and high-dose fractionated whole brain radiotherapy, and eventually improved neurologically and was discharged home on hospital day 48. Gefitinib and high-dose fractionated radiotherapy may have synergistic activity in patients with carcinomatous encephalitis from non-small cell lung cancer having favorable prognostic factors. More importantly, timely recognition of this disease and the use of large fraction radiation therapy are necessary to control rapid neurologic deterioration. |
| Other Sources: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721320/pdf/ |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:5119434 |
Contact administrator regarding this item (to report mistakes or request changes)